← Open Payments lookup

KATHRYN GRAMLICH: Open Payments

NPI 1710309588 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,088 in 68 payments from 18 companies in 2025. Trend: 2023 $2,689 · 2024 $2,168 · 2025 $1,088

Food & beverage: $1,088
CompanyPaymentsAmount
ABBVIE INC.16$237
Novo Nordisk Inc18$200
GlaxoSmithKline, LLC.6$117
Novartis Pharmaceuticals Corporation4$85
Verona Pharma, Inc.4$79
PFIZER INC.3$64
Exact Sciences Corporation3$49
Axsome Therapeutics, Inc.2$40
JAZZ PHARMACEUTICALS INC.1$39
Esperion Therapeutics, Inc.2$32

Products named: VRAYLAR, TRELEGY ELLIPTA, Ozempic, Ohtuvayre, LEQVIO, QULIPTA, ELIQUIS, Wegovy.

Industry payments across IN — which companies pay providers there.